Page last updated: 2024-11-06

prednisolone and Facial Hemiatrophy

prednisolone has been researched along with Facial Hemiatrophy in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.

Research Excerpts

ExcerptRelevanceReference
"We reported 2 cases of progressive hemifacial atrophy with different neurological manifestations from Kuwait."1.51Parry-Romberg syndrome in Kuwait. Neurological manifestations in 2 children. ( Al Enezi, S; Al Khalaf, MK; Al Mutairi, MA; Zakkiriah, M, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zakkiriah, M1
Al Khalaf, MK1
Al Mutairi, MA1
Al Enezi, S1
Miyamoto, M1
Kinoshita, M1
Tanaka, K1
Tanaka, M1

Other Studies

2 other studies available for prednisolone and Facial Hemiatrophy

ArticleYear
Parry-Romberg syndrome in Kuwait. Neurological manifestations in 2 children.
    Saudi medical journal, 2019, Volume: 40, Issue:7

    Topics: Adolescent; Anticonvulsants; Atrophy; Cerebrum; Child; Electroencephalography; Epilepsies, Partial;

2019
Recurrent myelitis in localized scleroderma.
    Clinical neurology and neurosurgery, 2014, Volume: 127

    Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Facial Hemiatrophy; Humans; Male; Myelitis

2014